Novel subtituted sulfonylurea and sulfoximineurea derivatives
AssigneeZydus Lifesciences Limited
InventorsRajiv SHARMA, Sameer AGARWAL
Life of this patent
Estimating the term…
Loading patent…
AssigneeZydus Lifesciences Limited
InventorsRajiv SHARMA, Sameer AGARWAL
Estimating the term…
The present invention relates to novel compounds of the general formula (I) their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers and polymorphs. The invention also relates to processes for the preparation of the compounds of invention, pharmaceutical compositions containing the compounds and their use as the compounds of the invention belong to the family of NOD-like receptor family (NLR) protein NLRP3 modulators. The present invention thus relates to novel NLRP3 modulators as well as to the use of the novel inhibitor compounds in the treatment of diseases or conditions in which interleukin 1β activity is implicated.
Compound having the structure of general formula (I)
Dependencies are inferred from the claim text.